MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Platinum-Resistant Epithelial Ovarian Cancer

  1. Home
  2. Diseases
  3. Platinum-Resistant Epithelial Ovarian Cancer
  4. Clinical Trials

Clinical Trials Related to Platinum-Resistant Epithelial Ovarian Cancer

Related studies linked through entity extraction aliases.

NCT06545617

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Status
WITHDRAWN
Phase
PHASE1/PHASE2

NCT05243524

Maveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer

Status
TERMINATED
Phase
PHASE2

NCT04244552

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Status
TERMINATED
Phase
PHASE1

NCT03081702

A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer

Status
COMPLETED
Phase
PHASE1/PHASE2

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.